US$ 20.93
glutathione in cancer simon Glutathione-mediated nanomedicines for diagnosis and therapy Glutathione-Dependent Pathways in Cancer Cells
Description
miyamotoi CA17-2241 (CP021873.1)

While these relationships have been known for years, most literature has overlooked these findings as the predictable result of increased inflammation and oxidative stress similar to other biomarkers such as C-reactive protein (CRP)

Gut (2005) 54:5039

Yang et alexpanded on these results, discovering RAS-selective lethal compound 3, later shown to be the inducer of ferroptosis (Zhang et al., 2004
